Table 1 Patient characteristics
Patient characteristics | n= | Percent |
|---|---|---|
Gender | ||
male | 22 | 20.0% |
female | 88 | 80.0% |
Age at radiotherapy | ||
Mean (SD) | 53 | 11.7 |
Median (Q1-Q3) | 52 | 29–85 |
Median (range) | 52 | 45–59 |
Histology | ||
WHO I | 60 | 54.5% |
WHO II | 7 | 6.4% |
WHO III | 1 | 0.9% |
unknown | 42 | 38.2% |
Location | ||
sphenoid wing | 42 | 38.2% |
petroclival | 23 | 20.9% |
sphenoorbital | 13 | 11.8% |
supra- and/or parasellar region | 10 | 9.1% |
sinus cavernosus | 4 | 3.6% |
olfactory | 4 | 3.6% |
tentorial fold | 3 | 2.7% |
petrosal | 5 | 4.5% |
cerebello-pontine angle | 3 | 2.7% |
foramen magnum | 3 | 2.7% |
Karnofsky performance score | ||
≥ 80% | 101 | 91.8% |
< 80% | 9 | 8.2% |
Previous surgery | ||
partial resection | 62 | 56.4% |
no surgery | 32 | 29.1% |
unknown | 9 | 8.2% |
biopsy | 4 | 3.6% |
complete resection | 3 | 2.7% |
treatment setting | ||
due to tumor progression | 51 | 46.4% |
definite | 42 | 38.2% |
adjuvant / additive | 17 | 15.5% |
Particle therapy | ||
protons | 104 | 94.5% |
carbon ions | 6 | 5.5% |